Case Study


Innovating For New Treatments And Cures

The Pharmaceutical Research and Manufacturers of America (PhRMA), represents the country’s leading innovative biopharmaceutical research companies. The membership is devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. PhRMA is committed to advancing public policies in the United States and around the world that support innovative medical research, yield progress for patients today and provides hope for the treatments and cures of tomorrow.

PhRMA biopharmaceutical graphic
PhRMA 340B Spotlight graphic
Educating Texans

The Monument Group guides Phrma’s public affairs communications efforts in Texas, including those related to its national communications campaign, GoBoldly. Our team develops a focused strategy to highlight the efforts of PhRMA’s innovative member companies.

Our team oversees campaign execution, develops content, provides strategic counsel, manages the media and coordinates thought leadership events to highlight innovations taking place in biopharmaceutical research. Our work also promotes the investments that PhRMA’s member companies are making to develop treatments and cures for diseases and the economic impact of these initiatives in Texas and across the country.